Комплексная оценка клинико-лабораторно-инструментальных показателей у пациентов с артериальной гипертензией в зависимости от особенностей ремоделирования левого предсердия
Диссертация
Несмотря на обилие научных фактов относительно патогенеза дилатации левого предсердия и прогностического значения этого процесса в общей популяции и среди пациентов высокого кардиоваскулярного риска, в отечественной литературе практически не освещены вопросы, касающиеся клинико-анамнестических проявлений, особенностей системной и внутрисердечной гемодинамики, состояния органов-мишеней, основных… Читать ещё >
Список литературы
- Бадаева C.B. Факторы риска гипертрофии миокарда при хронической болезни почек // Нефрология и диализ. — 2008. — Т. 10, № 2. — С. 94 104.
- Барсуков A.B., Багаева З. В., Пронина Е. В. и др. Гипертрофия левого желудочка при эссенциальной гипертензии: Актуальные вопросы патогенеза, диагностики и лечения // Артериальная гипертензия. 2009. — Т. 15, № 4. — С. 436 439.
- Бартош Ф.Л., Бартош Л. Ф., Адонина Т. С. Особенности диастолической функции левого желудочка у больных гипертонической болезнью с фибрилляцией предсердий // Артериальная гипертензия. 2012. -Т. 18, № 2. — С. 142−147.
- Беленков Ю.Н. Ремоделирование левого желудочка: Комплексный подход // Сердечная недостаточность. 2002. — Т.4, № 14. — С. 161−163.
- Гончаров Н.П. Современные методы гормонального анализа // Пробл. эндокринологии. 2011. — Т.56, № 1. — С. 86−91.
- Диагностика и лечение артериальной гипертензии. (Рекомендации Рос. мед. о-ва по артериальной гипертонии и Всерос. науч. о-ва кардиологов) // Кардиоваскулярная терапия и профилактика. 2008. — Т.7, № 6, прилож.2. — С. 228.
- Диагностика и лечение артериальной гипертензии. (Рекомендации Рос. мед. о-ва по артериальной гипертонии и Всерос. науч. о-а кардиологов) // Системные гипертензии. 2010. — № 3. — С. 5−26.
- Диагностика и лечение сахарного диабета, предиабета и сердечнососудистых заболеваний. (Рекомендации Европ. о-ва кардиологов и Европ. ассоц. по изучению сахарного диабета) // Сахарный диабет. 2008. — № 1. — С. 86−92.
- Иванов Н.В., Ворохобина Н. В., Чурина С. К. Влияние инсулина на функциональное состояние системы гипофиз-гонады у мужчин с артериальной гипертензии // Артериальная гипертензия. 2004. — Т. 10, №.1. — С. 46−48.
- Ивлева А .Я., Минина Е. С., Сивкова Е. Б. Превентивная терапия при мерцательной аритмии: Индивидуализированный подход к выбору антитромботического средства // Справочник поликлин, врача. 2006. — Т.4, № 5. — С. 20−24.
- Камкин А.Г., Киселева И. С., Ярыгин В. Н. Ионные механизмы механоэлектрической обратной связи у клеток сердца // Успехи физиол. наук. -2001. Т.32, № 2. — С. 75−104.
- Кобалава Ж. Д., Терещенко С. Н., Калинкин A.J1. Суточное мониторирование артериального давления: Методические аспекты и клиническое значение. М.: Б. и., 1997. — 32 с.
- Кушаковский М.С. Фибрилляция предсердий: Причины, механизмы, клинические формы, лечение и профилактика СПб.: Фолиант, 1999. — 176 с.
- Мареев В.Ю., Агеев Ф. Т., Арутюнов Г. П. и др. Диагностика и лечение хронической сердечной недостаточности. (Рекомендации всерос. науч. о-ва кардиологов) // Сердечная недостаточность. 2010 — Т.11, № 1 — С. 3−62.
- Насонов Е.Л., Панюкова Е. В., Александрова E.H. С-реактивный белок маркер воспаления при атеросклерозе // Кардиология. — 2002. — Т.42, № 7. — С. 53−62.
- Никитин А.Э., Гришаев С. Л., Свистов A.C. и др. Электрическая нестабильность миокарда: Причины, диагностика, лечение. СПб.: Агенство Вит-Принт, 2010.- 104 с.
- Оганов Р.Г., Мамедов М. Н. Национальные клинические рекомендации Всероссийского общества кардиологов. М.: Силицея-полиграф, 2009. — 528 с.
- Потешкина Н.Г., Джанашия П. Х. Структурно-функциональное ремоделирование миокарда и прогнозирование аритмий у больных артериальной гипертонией // Артериальная гипертензия. 2005. — Т.11, № 4. — С. 10−16.
- Реброва О.Ю. Статистичесий анализ медицинских данных. Применение пакета прикладных программ STATISTICA. М.: МедиаСфера, 2006. — 312 с.
- Сергиенко В.И., Бондарева И. Б. Математическая статистика в клинических исследованиях М.: ГЕОТАР-МЕД, 2001. — 256 с.
- Таланцева М.С. Состояние сердечно-сосудистой системы и нейрогуморальной регуляции кровообращения у лиц с артериальной гипертензией в сочетании с обструктивными заболеваниями легких: Автореф. дис.. канд. мед. наук. СПб., 2005. — 24 с.
- Тарасова О. А. Роль маркеров воспаления при фибрилляции предсердий // Врач-аспирант. 2007. — № 1. — С. 49−53.
- Татарский Б.А., Казенова Н. В., Серебряков Н. В. Прямой блокатор ренина при лечении пароксизмальной формы фибрилляции предсердий // Артериальная гипертензия. 2010. — Т. 16, № 1. — С. 74−81.
- Шальнова С. А. Эпидемиология артериальной гипертензии в России: Портрет больного // Артериальная гипертензия (клинический семинар). 2008. — Т.2, № 2. — С. 5−10.
- Шляхто Е.В., Конради А. О., Захаров A.B. и др. Структурно-функциональные изменения миокарда у больных гипертонической болезнью // Кардиология. 1999. — Т.39, № 2. — С. 49−55.
- Шляхто Е.В., Конради А. О. Ремоделирование сердца при гипертонической болезни патогенетические факторы и прогностическое значение // Науч. сб. «Кардиология СНГ». — СПб., 2003. — Т.1. — С. 20−25.
- Aksnes T.A., Flaa A., Strand A. et al. Prevention of new-onset atrial fibrillation and its predictors with angiotensin II-receptor blockers in the treatment of hypertension and heart failure // J.Hypertens. 2007. — Vol.25, № 1. — P. 15−23.
- Aksnes T. A., Schmieder R.E., Kjeldsen S.E. et al. Impact of new onset diabetes mellitus on development of atrial fibrillation and heart failure in high risk hypertension (from the VALUE Trial) // Amer.J.Cardiol. 2008. — Vol.101, № 5. — P. 634−638.
- Akutsu Y., Kaneko K., Kodama Y. et al. Iodine-123 mlBG imaging for predicting the development of atrial fibrillation // JACC: Cardiovasc.Imaging. 2011. — Vol.4, № 1. — P. 78−86.
- Anvar A.M., Geleijnse M.L., Soliman O.I. et al. Left atrial Frank-Starling law assessed by real-time, three-dimensional echocardiographic left atrial volume changes // Heart. 2007. — Vol.93, № 11. — P. 1393−1397.
- Aurigemma G.P., Gottdiener J.S., Shemanski L. et al. Predictive value of systolic and diastolic function for incident congestive heart failure in the elderly: The cardiovascular health study // J.Amer.Coll.Cardiol. 2001. — Vol.37, № 4. — P. 10 421 048.
- Ausma J., Coumans W.A., Duimel H. et al. Atrial high energy phosphate content and mitochondrial enzyme activity during chronic atrial fibrillation // Cardiovasc.Res. 2000. — Vol.47, № 4. — P. 788−796.
- Ausma J., Litjens N., Lenders M.H. et al. Time course of atrial fibrillation-induced cellular structural remodeling in atria of the goat // J.Mol.Cell.Cardiol. 2001. — Vol.33, № 12. — P. 2083−2094.
- Azzam Z.S., Saldias F.J., Cornelias A. et al. Catecholamines increase lung edema clearance in rats with increased left atrial pressure // J.Appl.Physiol. -2001. Vol.90, № 3. — P. 1088−1094.
- Bangalore S., Yao S.S., Chaudhry F.A. et al. Role of left atrial size in risk stratification and prognosis of patients undergoing stress echocardiography // J.Amer.Coll.Cardiol. 2007. — Vol.50, № 13. — P. 1254−1262.
- Baranchuk A., Healey J., Simpson С. et al. Atrial overdrive pacing in sleep apnea: A meta-analysis // Europace. 2009. — Vol.11, № 8. — P. 1037−1040.
- Barnes M.E., Miyasaka Y., Seward J.B., et al. Left atrial volume in the prediction of first ischemic stroke in an elderly cohort without atrial fibrillation // Mayo Clin.Proc. 2004. — Vol.79, № 8. — P. 1008−1014.
- Barsukov A., Bagaeva Z., Lokshina T. et al. Echocardiographic data in overweight essential hypertensive patients with different types of left ventricular hypertrophy // J.Hypertens. 2010. — Vol.28. № 6. — P. e568.
- Barsukov A., Pronina E., Shoustov S. Some predictors of asymmetric left ventricular hypertrophy forming in essential hypertension // J.Hypertens. 2011. -Vol.29, suppl.A.-P. 355.
- Benjamin E. J, D’Agostino R.B., Belanger A.J. et al. Left atrial size and the risk of stroke and death (The framingham heart study) // Circulation. 1995. -Vol.92, № 4. — P. 835−841.
- Bett G.C., Sachs F. Cardiac mechanosensitivity and stretch-activated ion channels // Trends Cardiovasc. Med. 1997. — Vol.7, № 1. — P 4−8.
- Bilo G. Giglio A., Styczkkiewicz K. et al. A new method for assessing 24-h blood pressure variability after excluding the contribution of noctural blood pressure fall // J.Hypertens. 2007. — Vol.25, № 10. — P. 2058−2066.
- Boldt A., Wetzel U., Weigl J. et al. Expression of angiotensin II receptors in human left and right atrial tissue in atrial fibrillation with and without underlying mitral valve disease // J.Amer.Coll.Cardiol. 2003. — Vol.42, № 10. — P. 1785−1792.r
- Bouzas-Mosquera A., Broullon F.J., Alvarez-Garcia N. et al. Left atrial size and risk for all-cause mortality and ischemic stroke // CMAJ. 2011. — Vol.183, № 10.-P. E657-E664.
- Brilla C.G., Matsubara L.S., Weber K.T. Anti-aldosterone treatment and the prevention of myocardial fibrosis in primary and secondary hyperaldosteronism // J.Mol.Cell.Cardiol. 1993. — Vol.25, № 5. — P. 563−575.
- Burstein B. Nattel S. Atrial fibrosis: Mechanisms and clinical relevance in atrial fibrillation // Amer.J.Coll.Cardiol. 2008. — Vol.51, № 8. — P. 801−809.
- Cabin H.S., Clubb K.S., Hall C. et al. Risk for systemic embolization of atrial fibrillation without mitral stenosis // Amer.J.Cardiol. 1990. — Vol.65, № 16. -P. 1112−1116.
- Carey R.M. Primary aldosteronism // Horm.Res. 2009. — Vol.71, suppl.l. — P. 8−12.
- Cheeivia A.N. Ahmed M.W., Kadish A.H. et al. Effects of autonomic stimulation and blockade on signal-averaged P wave duration // J.Amer.Coll.Cardiol.- 1995. Vol.26, № 2. — P. 497−502.
- Chen Y., Sato H., Watanabe N. et al. Factors influencing left atrial volume in treated hypertension // J.Cardiol. 2012. — Vol.60, № 2. — P. 133−138.
- Ciaroni S., Cuenoud L., Bloch A. Clinical study to investigate the predictive parameters for the onset of atrial fibrillation in patients with essential hypertension // Amer. Heart J. 2000. — Vol.139, № 5. — P. 814−819.
- Collier P., Watson C.J., Waterhouse D.F. et al. Progression of left atrial volume index in a population at risk for heart failure: A substudy of the STOP-HF trial // Europ.J.Heart Fail. 2012 — Vol.14, № 9. — P. 957−964.
- Conen D., Bamberg F. Noninvasive 24-h ambulatory blood pressure and cardiovascular disease: A systematic review and meta-analysis // J.Hypertens. 2008.- Vol.26, № 7. P. 1290−1299.
- Cujec B., Polasek P., Voll C. et al. Transesophageal echocardiography in the detection of potential cardiac source of embolism in stroke patients // Stroke. -1991. Vol.22, № 6. — P. 727−733.
- Cuspidi C., Negri F., Sala C. et al. Association of left atrial enlargement with left ventricular hypertrophy and diastolic dysfunction: A tissue doppler study in echocardiographic practice // Blood Pres. 2012. — Vol.21, № 1. — P. 24−30.
- Cuspidi C., Sala C., Negri F. et al. Prevalence of left-ventricular hypertrophy in hypertension: An updated review of echocardiographic studies // J.Hum.Hypertens. 2012. — Vol.26, № 6. — P. 343−349.
- Dahlof B., Devereux R., Kjeldsen S. Cardiovascular morbidity and mortality in the losartan intervention for endpoint reduction in hypertension study (LIFE): A randomized study against atenolol // Lancet. 2002. — Vol.359, № 9311. -P. 995−1003.
- Daniel W.G., Nellessen U., Schroder E. et al. Left atrial spontaneous echo contrast in mitral valve disease: An indicator for an increased thromboembolic risk // J.Amer.Coll.Cardiol. 1988. — Vol.11, № 6. — P. 1204−1211.
- Dernellis J., Panaretou M. Left atrial function in patients with a high C-reactive protein level and paroxysmal atrial fibrillation // Acta Cardiol. 2006. -Vol.61, № 5. — P. 507−511.
- Devereux, R.B., Alonso D.R., Lutas E.M. et al. Echocardiographic assessment of left ventricular hypertrophy: Comparison to necropsy findings // Amer.J.Cardiol. 1986. — Vol.57, № 6. — P. 450−458.
- Di Marco S., Barbier P., Dalla Vecchia L. et al. Relations between left atrial dimensions and compliance and dyslipidemia: Insights from the GILDA echocardiographic substudy // Europ. Heart J. 2008. — Vol.29, № 29. — P. 803.
- Di Tullio M.R., Sacco R.L., Sciacca R.R. et al. Left atrial size and the risk of ischemic stroke in an ethnically mixed population // Stroke. 1999. — Vol.30, № 10. — P. 2019−2024.
- Di Zhang A., Nguyen Dinh Cat A., Soukaseum C. et al. Cross-talk between mineralocorticoid and angiotensin II signaling for cardiac remodeling // Hypertension. 2008. — Vol.52, № 6. — P. 1060−1067.
- Dietz J.R. Mechanisms of atrial natriuretic peptide secretion from the atrium // Cardiovasc.Res. 2005. — Vol.68, № 1. — P. 8−17.
- Dorian P., Singh B.N. Upstream therapies to prevent atrial fi brillation // Europ. Heart J. 2008. — Vol.10, suppl.H. — P. Hl 1-H31.
- Druzbacka L., Valocik G., Jakubova M. et al. Clinical implications of enlargement of left atrium // Vnitr.Lek. 2012. — Vol.58, № 2. — P. 118−122.
- DuBois D., DuBois D.F. A formula to estimate the approximate surface area if height and weight be known (1916) // Nutrition. 1989. — Vol.5, № 5. — P. 303 311.
- Duru M, Seyfeli E, Kuvandik et al. Effect of weight loss on P wave dispersion in obese subjects // Obesity (Silver Spring). 2006. — Vol.14, № 8. — P. 1378−1382.
- Egan B.M., Stepniakowski K., Goodfriend T.L. Renin and aldosterone are higher and the hyperinsulinemic effect of salt restriction greater in subjects with risk factors clustering //AmerJ.Hypertens. 1994. — Vol.7, № 10. — P. 886−893.
- Emdin M., Gastaldelli A., Muscelli E. et al. Hyperinsulinemia and autonomic nervous system dysfunction in obesity: Effects of weight loss // Circulation. 2001. — Vol.103, № 4. — P. 513−519.
- Emdin M., Gastaldelli A., Muscelli E. Et al. Hyperinsulinemia and autonomic nervous system dysfunction in obesity: Effects of weight loss // Circulation. 2001. — Vol.103, № 4. — P. 513−519.
- Ermis N., Acikgoz N., Cuglan B. et al. Comparison of atrial electromechanical coupling interval and P-wave dispersion in non-dipper versus dipper hypertensive subjects // Blood Press. 2010. — Vol.20, № 1. — P. 60−66.
- Festa A., D’Agostino R., Howard G. et al. Chronic subclinical inflammation as part of the insulin resistance syndrome: The insulin resistance atherosclerosis study // Circulation. 2000. — Vol.102, № 1. — P. 42−47.
- Finckenberg P., Eriksson O., Baumann M. et al. Caloric restriction ameliorates angiotensin II-induced mitochondrial remodeling and cardiac hypertrophy // Hypertension. 2012. — Vol.59, № 1. — P. 76−84.
- Fogari R., Zoppi A., Maffioli P. et al. Effect of telmisartan on paroxysmal atrial fibrillation recurrence in hypertensive patients with normal or increased left atrial size // Clin.Cardiol. 2012. — Vol.35, № 6. — P. 359−64.
- Fratolla A., Parati G., Cuspidi C. et al. Prognostic value of 24-hour pressure variability // J.Hypertens. 1993. — Vol.11, № 10. — P. 1133−1137.
- Galderisi M., Petrocelli A., Fakher A. et al. Influence of nighttime blood pressure on left atrial size in uncomplicated arterial systemic hypertension // Amer.J.Hypertens. 1997. — Vol.10, № 8. — P. 836−842.
- Garni A.S., Hodges D.O., Herges R.M. et al. Obstructive sleep apnea, obesity, and the risk of incident atrial fibrillation // J.Amer.Coll.Cardiol. 2007. -Vol.49, № 5. — P. 565−571.
- Ganau A., Devereux R.B., Roman M. J et al. Patterns of left ventricular hypertrophy and geometric remodeling in essential hypertension // J.Amer.Coll.Cardiol. 1992. — Vol.19, № 7. — P. 1550−1558.
- Garanty-Bogacka B., Syrenicz M., Syrenicz A. et al. Relation of acute-phase reaction and endothelial activation to insulin resistance and adiposity in obese children and adolescents //Neuroendocrinol.Lett. 2005. — Vol.26, № 5. — P. 473−479.
- Gerdts E., Wachtell K., Omvik P. et al. Left atrial size and risk of major cardiovascular events during antihypertensive treatment: Losartan intervention for endpoint reduction in hypertension trial // Hypertension. 2007. — Vol.49, № 2. — P. 311−316.
- Gershlick A. H. Treating the non-electrical risks of atrial fibrillation // Europ. Heart J. 1997. — Vol.18, suppl.C. — P. 19−26.
- Gillman M.W., Kannel W.B., Belanger A. et al. Influence of heart rate on mortality among persons with hypertension: The framingham study // Amer. Heart J. 1993.-Vol.125, № 4.-P. 1148−54.
- Goette A., Staack T., Rocken C. et al. Increased expression of extracellular signal-regulated kinase and angiotensin-converting enzyme in human atria during atrial fibrillation // J.Amer.Coll.Cardiol. 2000. — Vol.35, № 6. — P. 16 691 677.
- Gottdiener J.S. Reda D.J., Williams D.W. et al. Effect of single-drug therapy on reduction of left atrial size in mild to moderate hypertension: Comparison of six antihypertensive agents // Circulation. 1998. — Vol.98, № 2. — P. 140−148.
- Govindarajan G. Obesity and hypertension: A clinical update // Molecular mechanisms in hypertension. London, 2006. — P. 397−406.
- Graf K., Schaefer-Graf U.M. Is Smad3 the key to infl ammation and fibrosis in hypertensive heart disease? // Hypertension. 2010. — Vol.55, № 5. — P. 1088−1089.
- Hamby R.I., Zeldis S.M., Hoffman I. et al. Left atrial size and left ventricular function in coronary artery disease: An echocardiographic-angiographic correlative study // Cathet.Cardiovasc.Diagn. 1982 — Vol.8, № 2. — P. 173−183.
- Henareh L., Jogestrand T., Agewall S. Glucose intolerance is associated with C-reactive protein and intimamedia anatomy of the common carotid artery in patients with coronary heart disease // Diabet.Med. 2005. — Vol.22, № 9. — P. 12 121 217.
- Hirschler V., Acebo H.L., Fernandez G.B. et al. Influence of obesity and insulin resistance on left atrial size in children // Pediatr.Diabetes. 2006. — Vol.7, № 1. — P. 39−44.
- Hirschler V., Perez Acebo H.L., Fernandez G.B. et al. Association between left atrial size and measures of adiposity among normal adolescent boys // Pediatric.Cardiol. 2012. — Vol.33, № 2. — P. 245−251.
- Houmsse M., Tyler J., Kalbfleisch S. Supraventricular tachycardia causing heart failure // Curr.Opin.Cardiol. 2011. — Vol.26, № 3. — P. 261−269.
- Johansen O.E., Brustad E., Enger S. et al. Prevalence of abnormal glucose metabolism in atrial fibrillation: A case control study in 75-year old subjects // Cardiovasc.Diabetol. 2008. — Vol.7, № 1. — P. 28.
- Julius S., Palatini P., Kjeldsen S. et al. Tachycardia predicts cardiovascular events in the VALUE trial 2010 // J.Clin.Hypertens. 2010. — Vol.12, № 7.-P. 529−533.
- Kamkin A. Kiseleva I., Wagner K.D. et al. Mechano-electric feedback in right atrium after ventricular in arction in rats // J.Mol.Cell.Cardiol. 2000. — Vol.33, № 3. — P. 465−477.
- Kannel W.B., Wolf P.A., Benjamin E.J. et al. Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: Population-based estimates // Amer.J.Cardiol. 1998. — Vol.82, № 8A. — P. 2N-9N.
- Kasi V.S., Xiao H.D., Shang L.L. et al. Cardiac-restricted angiotensin-converting enzyme overexpression causes conduction defects and connexin dysregulation // Amer.J.Physiol.Heart.Circ.Physiol. 2007. — Vol.293, № 1. — P. H182-H192.
- Keller A.M., Gopal A.S., King D.L. Left and right atrial volume by freehand three-dimensional echocardiography: In vivo validation using magnetic resonance imaging // Europ.J.Echocardiogr. 2000. — Vol.1, № 1. — P. 55−65.
- Kiec-Wilk B., Kawecka-Laszcz K., Stolarz K. et al. Growth factors and cytokines (TGFBeta, bFGF and IGF-1) and cardiac left ventricular hypertrophy in hypertension // Kardiol.Pol. 2006. — Vol.64, № 10, suppl.6. — P. S586-S590.
- Kim B.K., Lim Y.H., Lee H.T. et al. Non-dipper pattern is a determinant of the inappropriateness of left ventricular mass in essential hypertensive patients // Korean.Circ.J. 2011. — Vol.41, № 4. — P. 191−197.
- Kizer J.R., Bella J.N., Palmieri V. et al. Left atrial diameter as an independent predictor of first clinical cardiovascular events in middle-aged and elderly adults: the strong heart study // Amer. Heart J. 2006. — Vol.151, № 2. — P. 412 418.
- Kotsis V., Stabouli S., Papakatsika S. et al. Mechanisms of obesity-induced hypertension // Hypertens.Res. 2010. — Vol.33, № 5. — P. 386−393.
- Krahn A. D., Manfreda J., Tate R.B. et al. The natural history of atrial fibrillation: incidence, risk factors, and prognosis in the manitoba follow-up study // Amer.J.Med. 1995. — Vol.98, № 5. — P. 476−484.
- Kurdi M., Booz G.W. New Take on the Role of angiotensin II in cardiac hypertrophy and fibrosis // Hypertension. 2011. — Vol.57, № 6. — P. 1034−1038.
- Kuwahara F., Kai H., Tokuda K. et al. Hypertensive myocardial fibrosis and diastolic dysfunction: Another model of inflammation? // Hypertension. 2004. -Vol.43, № 4. — P. 739−745.
- L’Allier P.L., Ducharme A., Keller P. et al. Angiotensin-Converting enzyme inhibition in hypertensive patients is associated with a reduction in the occurrence of atrial fibrillation // J.Amer.Coll.Cardiol. 2004. — Vol.44, № 1. — P. 159 164.
- Echocardiography, a branch of the European Society of Cardiology // J.Amer.Soc.Echocardiogr. 2005. — Vol.18, № 12. — P. 1440−1463.
- Laukkanen J.A., Kurl S., Eranen J. et al. Left atrium size and the risk of cardiovascular death in middle-aged men // Arch.Int.Med. 2005. — Vol.165, № 12. -P. 1788−1793.
- Lee R.J., Bartzokis T., Yeoh T.K. et al. Enhanced detection of intracardiac sources of emboli by transesophageal echocardiography // Stroke. 1991. -Vol.22, № 12.-P. 734−739.
- Lester S.J., Ryan E.W., Schiller N.B. et al. Best method in clinical practice and in research studies to determine left atrial size // Amer.J.Cardiol. 1999. — Vol.84, № 7. — P. 829−832.
- Levy S. Epidemiology of atrial fibrillation: Clinical implication and relevance to therapy // Practical therapeutic strategies for atrial frillation: Tests of simposium held in conjuction with Europace 97. Athens, 1997. — P. 2345.
- Lijnen P., Petrov V. Introduction of cardiac fibrosis by aldosterone // J.Mol.Cell.Cardiol. 2000. — Vol.32, № 6. — P. 865−879.
- Lind L., Anderson P.E., Andren B. et al. Left ventricular hypertrophy in hypertension is associated with the insulin resistance metabolic syndrome // J.Hypertens. 1995. — Vol.13, № 4. — P. 433−438.
- Luther J. Brown N. The renin-angiotensin-aldosterone system and glucose homeostasis // Trends Pharmacol. Sei. 2011. — Vol.32, №.12. — P. 734−739.
- Madu E.C., Baugh D.S., Gbadebo T.D. et al. Effect of ethnicity and hypertension on atrial conduction: Evaluation with high-resolution P-wave signal averaging // Clin.Cardiol. 2001. — Vol.24, № 9. — P. 597−602.
- Maggioni A.P., Latini R., Carson P.E. et al. Valsartan reduces the incidence of atrial fibrillation in patients with heart failure: Results from the valsartan heart failure trial // Amer. Heart J. 2005. — Vol.149, № 3. — P. 548−557.
- Mathers C., Stevens G., Mascarenhas M. Global health risks: Mortality and burden of disease attributable to selected major risks // Geneva: World Health Organzation. 2009. — 70 p.
- Mattioli A.V., Vivoli D., Bastia E. Doppler echocardiography parameters predictive of recurrence of atrial fibrillation of different etiologic origins // J.Ultrasound.Med. 1997. — Vol.16, № 10. — P. 695−698.
- McEwan P., Gray G., Cherry L. et al. Differential effects of angiotensin II on cardiac cell proliferation and intramyocardial pericascular fibrosis // Circulation.- 1998. Vol.98, № 24. — P. 2765−2773.
- Milan A., Puglisi E., Magnino C. et al. Left atrial enlargement in essential hypertension: Role in the assessment of subclinical hypertensive heart disease // Blood Press. 2012. — Vol.21, № 2. — P. 88−96.
- Miller J.T., O’Rourke R.A., Crawford M.H. Left atrial enlargement: An early sign of hypertensive heart disease // Amer. Heart J. 1988. — Vol.116, № 4. — P. 1048−1051.
- Moller J.E., Hillis G.S., Oh J.K. et al. Left atrial volume: A powerful predictor of survival after acute myocardial infarction // Circulation. 2003. -Vol.107, № 17. — P. 2207−2212.
- Moran A., Steffen L.M., Steinberger J. et al. Relation of C-reactive protein to insulin resistance and cardiovascular risk factors in youth // Diabetes Care.- 2005. Vol.28, № 7. — P. 1763−1768.
- Morgan D.A., Anderson E.A., Mark A.L. Renal sympathetic nerve activity is increased in obese Zucker rats // Hypertension. 1995. — Vol.25, № 4. — P. 834−843.
- Nakamura N.H., Kohara K., Sumimoto T. et al. Glucose intolerance exaggerates left ventricular hypertrophy in essential hypertension // Amer.J.Hypertens. 1994. — Vol.7, № 12. — P. 1110−1114.
- Nakamura T., Kataoka K., Fukuda M. et al. Critical role of apoptosis signal-regulating kinase 1 in aldosterone/salt-induced cardiac inflammation and fibrosis // Hypertension. 2009. — Vol.54, № 3. — P. 544−551.
- Nakashima H., Kumagai K., Urata H. et al. Angiotensin II antagonist prevents electrical remodeling in atrial fibrillation // Circulation. 2000. — Vol.101, № 22.-P. 2612−2617.
- Nattel S. Driver regions in atrial fibrillation associated with congestive heart failure: Where are they, and what are they telling us? // J.Cardiovasc.Electrophysiol. 2005. — Vol.16, № 12. — P. 1359−1361.
- Nistri S., Olivotto I., Betocchi S. et al. Prognostic significance of left atrial size in patients with hypertrophic cardiomyopathy // Amer.J.Cardiol. 2006. -Vol.98, № 7. — P. 960−965.
- Oakley C. Genesis of arrhythmias in the failing heart and therapeutic implications // Amer.J.Cardiol. 1991. — Vol.67, № 12. — P. 26C-28C.
- Palatini P., Thijs L., Staessen J.A. et al. Predictive value of clinic and ambulatory heart rate for mortality in elderly subjects with systolic hypertension free // Arch.Int.Med. 2002. — Vol.162, № 20. — P. 2313−2321.
- Park C.S., An G.H., Kim Y.W. et al. Evaluation of the relationship between circadian blood pressure variation and left atrial function using strain imaging // J.Cardiovasc.Ultrasound. 2011. — Vol.19, № 4. — P. 183−191.
- Pearlman N.W., Meyers A.D., Sullivan W.G. et al. Muscle fiber orientation and connective tissue content in the hypertrophied human heart // Lab.Invest. 1982. — Vol.46, № 2. — P. 158−164.
- Phillips G.B., Jing T.Y., Laragh J.H. et al. Serum sex hormone levels and renin-sodium profile in men with hypertension //Amer.J.Hypertens. 1995. — Vol.8, № 6. — P. 626−629.
- Piotrowski G., Maciej M., Gerdts E. et al. Left atrial size in hypertension and stroke // Hypertension. 2011. — Vol.29, № 10. — P. 1988−1993.
- Poutanen T., Ikonen A., Vainio P. et al. Left atrial volume assessed by transthoracic three-dimensional echocardiography and magnetic resonance imaging: Dynamic changes during the heart cycle in children // Heart. 2000. — Vol.83, № 5. -P. 537−542.
- Psaty B.M., Manolio T.A., Kuller L.H. et al. Incidence of and risk factors for atrial fibrillation in older adults // Circulation. 1997. — Vol.96, № 7. — P. 2455−2461.
- Reed D., Abbott R.D., Smucker M.L. et al. Prediction of outcome after mitral valve replacement in patients with symptomatic chronic mitral regurgitation. The importance of left atrial size // Circulation. 1991. — Vol.84, № 1. — P. 23−34.
- Reichek N., Devereux R.B. Left ventricular hypertrophy: Relationship of anatomic, echocardiographic and electrocardiographic findings // Circulation. 1981. -Vol.63, № 6. — P. 1391−1398.
- Rodrigues A.C., Scannavacca M.L., Caldas M.A. et al. Left atrial function after ablation for paroxysmal atrial fibriiation // Amer.J.Cardiol. 2009. -Vol.103, № 3.-P. 395−398.
- Rossi A., Tomaino M., Golia G. et al. Usefulness of left atrial size in predicting postoperative symptomatic improvement in patients with aortic stenosis // Amer.J.Cardiol. 2000. — Vol.86, № 5. — P. 567−70.
- Rossi A., Cicoira M., Zanolla L. et al. Determinants and prognostic value of left atrial volume in patients with dilated cardiomyopathy // J.Amer.Coll.Cardiol. -2002. Vol.40, № 8. — P. 1425−1430.
- Rutter M.K., Meigs J.B., Sullivan L.M. et al. C-reactive protein, the metabolic syndrome, and prediction of cardiovascular events in the framingham offspring study // Circulation. 2004. — Vol.110, № 4. — P. 380−385.
- Saraiva R.M., Yamano T., Matsumra Y. et al. Left atrial function assessed by real-time 3-dimensional echocardiography is related to right ventricular systolie pressure in chronic mitral regurgitation // Amer. Heart J. 2009. — Vol.158, № 2.-P. 309−316.
- Sartori C., Scherrer U. Insulin, nitric oxide and the sympathetic nervous system: At the crossroads of metabolic and cardiovascular regulation //J.Hypertens. -1999. -Vol.17, № 11. -P. 1517−1525.
- Sarubbi B., Ducceschi V., D’Andrea A. et al. Atrial fibrillation: What are the effects of drug therapy on the effectiveness and complications of electrical cardioversion? // Canad.J.Cardiol. 1998. — Vol.14, № 10. — P. 1267−1273.
- Sasson Z., Rasooly Y., Gupta R. et al. Left atrial enlargement in healthy obese: Prevalence and relation to left ventricular mass and diastolic function // Canad.J.Cardiol. 1996. — Vol.12, № 3. — P. 257−263.
- Schindler C. The metabolic syndrome as an endocrine disease: Is there an effective pharmacotherapeutic strategy optimally targeting the pathogenesis? // Ther.Adv.Cardiovasc.Dis. 2007.-- Vol.-l, №.1. — P. 7−26.
- Seo H.S., Kang T.S., Park S. et al. Non-dippers are associated with adverse cardiac remodeling and dysfunction (Rl) // Intern.J.Cardiol. 2006. -Vol.112, № 2. — P. 171−177.
- Shang L.L., Sanyal S., Pfahnl A.E. et al. NF-kappaB-dependent transcriptional regulation of the cardiac scn5a sodium channel by angiotensin II // Amer.J.Physiol.Cell.Physiol. 2008. — Vol.294, № 1. — P. 372−379.
- Sharma A.M., Janke J., Gorzelniak K. et al. Angiotensin blockade prevents type 2 diabetes by formation of fat cells // Hypertension. 2002. — Vol.40, № 5.-P. 609−611.
- Shigematsu Y., Hara Y., Ohtsuka T. et al. Relation of genetic predisposition and insulin resistance to left ventricular hypertrophy in hypertension // Amer.J.Hypertens. 2005. — Vol.18, № 4. — P. 457−463.
- Sundstrum J., Lind L., Nystrum N. et al. Left ventricular concentric remodeling rather than left ventricular hypertrophy related to insulin resistance syndrome in the elderly // Circulation. 2000. — Vol.101, № 22. — P. 2595−2600.
- Tabata T., Oki T., Fukuda N. et al. Influence of left atrial pressure on left atrial appendage flow velocity patterns in patients in sinus rhythm // J.Amer.Soc.Echocardiogr. 1996. — Vol.9, №.6. — P. 857−864.
- Tagawa H., Wang N., Narishige T. et al. Cytoskeletal mechanics in pressure-overload cardiac hypertrophy // Circ.Res. 1997. — Vol.80, № 2: — P: 281- -289.
- Teichholz L.E., Cohen M.V., Sonnenblick E.H. et al. Study of left ventricular geometry and function by B-scan ultrasonography in patients with and without asynergy //N.Engl.J.Med. 1974. — Vol.291, № 23. — P. 1220−1226.
- Tripepi G., Mattace-Raso F., Mallamaci F. et al. Biomarkers of left atrial volume: A longitudinal study in patients with end stage renal disease // Hypertension. -2009 -Vol.54, № 4. P. 818−824.
- Tsang T.S., Barnes M.E., Gersh B.J. et al. Prediction of risk for first age-related cardiovascular events in an elderly population: The incremental value of echocardiography // J.Amer.Coll.Cardiol. 2003. — Vol.42, № 7. — P. 1199−205.
- Tsang T.S., Abhayaratna W.P., Barnes M.E. et al. Prediction of cardiovascular outcomes with left atrial size: is volume superior to area or diameter? // J.Amer.Coll.Cardiol. 2006. — Vol.47, № 5. — P. 1018−23.
- Tsutsui J., Dourado P., Elhendy A. et al. Prognostic value of left atrial volume in patients who underwent dobutamine stress echocardiography for known or suspected coronary artery disease // Amer. Heart J. 2008. — Vol.156, № 6. — P. 11 101 116.
- Vasan R.S., Lee D.S. Goals and guidelines for treating hypertension in a patient with heart failure // Curr.Treat.Options.Cardiovasc.Med. 2006. — Vol.8, №.4. -P. 334−344. • — ---- • ----
- Vasan R.S., Glazer N.L., Felix J.F. et al. Genetic variants associated with cardiac structure and function: A meta-analysis and replication of genome-wide association data // JAMA. 2009. — Vol.302, №.2. — P. 168−178.
- Vaziri S.M., Larson M.G., Lauer M.S. et al. Influence of blood pressure on left atrial size. The framingham heart study // Hypertension. 1995. — Vol.25, № 6. -P. 1155−1160.
- Verdecchia P., Reboldi G.P., Gattobigio R. et al. Atrial fibrillation in hypertension: Predictors and outcome // Hypertension. 2003. — Vol.41, № 2. — P. 218 223.
- Wanahita N., Messerli F.H., Bangalore S. et al. Atrial fibrillation and obesity results of a meta-analysis // Amer. Heart J. — 2008. — Vol.155, № 2. — P. 310 315.
- Watanabe K., Sekiya M., Tsuruoka T. et al. Effect of insulin resistance on left ventricular hypertrophy and dysfunction in essential hypertension // J.Hypertens. 1999. — Vol.17, № 8. — P. 1153−1160.
- Watanabe T., Takeishi Y., Hirono O. et al. C-reactive protein elevation predicts the occurrence of atrial structural remodeling in patients with paroxysmal atrial fibrillation // Heart Vessels. 2005. — Vol.20, № 2. — P. 45−49.
- Watson T., Karthikeyan V.J., Lip G. et al. Atrial fibrillation in primary aldosteronism // J. Renin-Ang.-Ald.Syst. 2009. — Vol.10, № 4. — P. 190−194.
- Xu J., Carretero O.A., Liao T. D et al. Local angiotensin II aggravates cardiac remodeling in hypertension // Amer.J.Physiol.Heart Circ.Physiol. 2010 -Vol.299 № 5. — P. H1328-H1338.
- Yagi S., Akaike M., Aihara K. et al. Endothelial nitric oxide synthase-independent protective action of statin against angiotensin II-induced atrial remodeling via reduced oxidant injury // Hypertension. 2010. — Vol.55, № 4. — P. 918−923.
- Yallow R. S., Berson S. A. Immunoassay and endogenous plasma insulin in man // J.Clin.Invest. 1960. — Vol.39, № 7. — P. 1157−1165.
- Yu W., Chen S., Lee S. et al. Tachicardia-induced change of atrial refrectory period in humans: Rate dependency and effects of antiarrhythmic drugs // Circulation. 2006. — Vol.97, № 23. — P. 2331−2337.
- Zeng T., Bett G.C., Sachs F. et al. Stretch-activated whole cell currents in cardiac myocytes // Amer.J.Physiol. 2000. — Vol.278, № 2. — P. H548-H557.
- Zhang J., Qin Y., Zheng X. et al. The relationship between human serum resistin level and body fat content, plasma glucose as well as blood pressure // Zhonghua Yi Xue Za Zhi. 2002. — Vol.82, № 23. — P. 1609−1612.
- Zhang Y., Li Y., Liu M. et al. Cardiac structure and function in relation to cardiovascular risk factors in Chinese // BMC.Cardiovasc.Dis. 2012. — Vol.12, № 1. — P. 86.